The AI engine Fit Assessment
BetaThe company will attend Deep Tech Momentum 2026
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
Provider of engineered cellular therapies intended for the treatment of blood cancers and autoimmune disorders. The company offers engineered CAR T cells targeting and a microRNA-based amplifier, enabling clinical researchers and oncologists to explore more precise and effective cancer treatment options.